Alector (ALEC) EBT Margin (2018 - 2026)

Alector's (ALEC) quarterly EBT Margin came in at 2192.16% in Q1 2026, down 109061.0% year-on-year from N/an in Q1 2025, and down 268.54% on a QoQ basis from 594.82% in Q4 2025.

Alector (ALEC) EBT Margin (2018 - 2026) Analysis & Trends

Alector (ALEC) has 9 years of EBT Margin data on file, last reported at 2192.16% in Q1 2026.

  • On a quarterly basis, EBT Margin fell 109061.0% year-over-year to 2192.16% in Q1 2026; TTM through Mar 2026 was 679.92%, a 54032.0% decrease from a year earlier, with the FY2025 full-year figure at 678.36%, down 56010.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 2192.16%, down from 594.82% in the prior quarter.
  • Over the last five years, EBT Margin for ALEC reached as high as 13.68% in Q2 2022 and fell as low as 2192.16% in Q1 2026.
  • Historically, EBT Margin has averaged 466.7% across 5 years, with a median of 275.19% in 2024.
  • Across the five-year window, EBT Margin surged 109016 bps in 2022 and tumbled 109061 bps in 2026, its largest moves.
  • Year by year, EBT Margin stood at 358.08% in 2022, then climbed by 27 bps to 261.8% in 2023, then soared by 99 bps to 3.74% in 2024, then plunged by 15825 bps to 594.82% in 2025, then slumped by 269 bps to 2192.16% in 2026.
  • Per Business Quant data, the three most recent EBT Margin figures were 2192.16% in Q1 2026, 594.82% in Q4 2025, and 1063.4% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Alector 164.78 Mn -41.74 Mn - -2,192.16%

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,192.16%
Dec 31, 2025 -594.82%
Sep 30, 2025 -1,063.40%
Jun 30, 2025 -387.66%
Mar 31, 2025 -1,101.55%
Dec 31, 2024 -3.74%
Sep 30, 2024 -275.19%
Jun 30, 2024 -255.94%
Mar 31, 2024 -226.97%
Dec 31, 2023 -261.80%
Sep 30, 2023 -474.51%
Jun 30, 2023 4.92%
Mar 31, 2023 -271.65%
Dec 31, 2022 -358.08%
Sep 30, 2022 -305.78%
Jun 30, 2022 13.68%
Mar 31, 2022 -179.21%
Dec 31, 2021 -397.37%
Sep 30, 2021 69.40%
Jun 30, 2021 -839.63%